$27.29
-0.19-0.69%
Last update: Oct 12, 10:35 AM
$27.39
-0.0875-0.32%
Parabilis Medicines Inc (PBLS) Stock Price, Quote, News & History
PBLSNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Parabilis Medicines (NASDAQ:PBLS) through any online brokerage.
Other companies in Parabilis Medicines’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Parabilis Medicines has a consensus price target of $41.67.
The stock price for Parabilis Medicines (NASDAQ: PBLS) is $27.29 last updated October 12, 2026 at 10:35 AM EDT.
There are no upcoming dividends for Parabilis Medicines.
Parabilis Medicines does not have any upcoming earnings scheduled.
There is no upcoming split for Parabilis Medicines.
Parabilis Medicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide...
